Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc.（COLL）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
coll · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$60.00
Consensus
$58.00
+73.4% upside
Low
$56.00
Median: $58 · Last Close: $33.44
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$58.00
73.4% upside
High Target
$60
79.4%
Low Target
$56
67.5%
Current Price
$33.44
as of today
Based on analyst price targets, the COLL stock price prediction for the next 12 months ranges from $56 to $60. The consensus COLL price forecast of $58.00 implies 73.4% upside from the current price of $33.44.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $32.47 | ↓ 2.90% |
1-day model range: $32.3–$32.64. Peak: $32.64 (-2.90%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $40 | +19.2% |
| 2028 | $44 | +31.9% |
| 2029 | $47 | +39.5% |
| 2030 | $48 | +44.0% |
| 2031 | — | +46.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · COLL · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-19 | Needham | Maintains | Buy→Buy |
| 2026-02-26 | Needham | Maintains | Buy→Buy |
| 2026-01-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-09 | Barclays | Maintains | Overweight→Overweight |
| 2026-01-08 | Needham | Maintains | Buy→Buy |
| 2025-11-07 | Truist Securities | Maintains | Buy→Buy |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-28 | Needham | Maintains | Buy→Buy |
| 2025-05-09 | Piper Sandler | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Collegium Pharmaceutical, Inc. (COLL) stock. Of the recent 65 rating actions, 3 were upgrades and 5 were downgrades. 12 analysts currently cover COLL.
分析师推荐趋势
COLL analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$875M
↑ 4.9% YoY
Revenue Next Year
$886M
↑ 1.3% YoY
EPS This Year
$7.72
EPS Next Year
$7.61
↓ 1.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast COLL EPS of $7.72 for the current fiscal year, based on estimates from 3 analysts. The COLL revenue forecast is $875M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
COLL 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。COLL 的共识目标价为 $58.00（+73.4% 上行空间），分析师共识为 Buy。
COLL 的短期预测（明日）为 $32.47（-2.90%）。 COLL 对 2027 年的股价预测均值为 $40。 COLL 对 2030 年的预测区间为 $45–$51。
Collegium Pharmaceutical, Inc. 在 NASDAQ 上市，代码 COLL。COLL 在 2027 年的整体展望偏积极，在覆盖分析师中约 67% 对应 Buy 共识。
常见问题
COLL 预测 · 8 个问题根据 12 位华尔街分析师，COLL 的 12 个月平均目标价为 $58.00，最高 $60.00、最低 $56.00。若有图表，中位目标价可在上方查看。相对当前价 $33.44，隐含约 +73.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.